Laser Photonics Subsidiary Control Micro Systems (CMS) Announces Orders from Pharmaceutical and Electronics Manufacturing Clients
Laser Photonics (NASDAQ: LASE) announced that its subsidiary Control Micro Systems (CMS) has secured multiple follow-on orders for advanced laser systems from pharmaceutical and electronics manufacturing clients. The orders include a UV Laser Drilling System from a leading pharmaceutical company and a PCB Laser Marking Workstation for circuit board manufacturing.
The UV Laser Drilling System features water-cooling and an integrated through-the-optics vision system for precise hole drilling. The PCB Laser Marking Workstation, powered by an air-cooled CO2 laser, offers custom conveyor configurations and sophisticated vision systems for tight-tolerance alignment. Both systems include CDRH Class I compliant enclosures and are programmed using CMS's proprietary software.
Since its acquisition by LPC in Q4 2024, CMS has shown rapid growth in specialized laser equipment for pharmaceutical, PCB manufacturing, and wire processing applications, expanding LPC's market presence.
Laser Photonics (NASDAQ: LASE) ha annunciato che la sua sussidiaria Control Micro Systems (CMS) ha ottenuto numerosi ordini di follow-up per sistemi laser avanzati da clienti nei settori farmaceutico e della produzione di elettronica. Gli ordini includono un Sistema di Foratura Laser UV da parte di una delle principali aziende farmaceutiche e una Postazione di Marcatura Laser PCB per la produzione di circuiti stampati.
Il Sistema di Foratura Laser UV è dotato di raffreddamento ad acqua e di un sistema di visione ottica integrato per forature precise. La Postazione di Marcatura Laser PCB, alimentata da un laser CO2 raffreddato ad aria, offre configurazioni di nastro trasportatore personalizzate e sistemi di visione sofisticati per un allineamento a tolleranze strette. Entrambi i sistemi includono contenitori conformi alla Classe I CDRH e sono programmati utilizzando il software proprietario di CMS.
Dall'acquisizione da parte di LPC nel quarto trimestre del 2024, CMS ha mostrato una rapida crescita nella fornitura di attrezzature laser specializzate per applicazioni farmaceutiche, di produzione PCB e di lavorazione dei fili, ampliando la presenza di mercato di LPC.
Laser Photonics (NASDAQ: LASE) anunció que su filial Control Micro Systems (CMS) ha asegurado múltiples pedidos de seguimiento para sistemas láser avanzados de clientes en la industria farmacéutica y de fabricación de electrónica. Los pedidos incluyen un Sistema de Perforación Láser UV de una de las principales compañías farmacéuticas y una Estación de Marcado Láser de PCB para la fabricación de placas de circuito.
El Sistema de Perforación Láser UV cuenta con refrigeración por agua y un sistema de visión a través de ópticas integrado para perforaciones precisas. La Estación de Marcado Láser de PCB, impulsada por un láser CO2 refrigerado por aire, ofrece configuraciones personalizadas de cinta transportadora y sistemas de visión sofisticados para un alineamiento de tolerancias estrechas. Ambos sistemas incluyen cajas conforme a la Clase I de CDRH y están programados utilizando el software propietario de CMS.
Desde su adquisición por parte de LPC en el cuarto trimestre de 2024, CMS ha mostrado un rápido crecimiento en equipos láser especializados para aplicaciones farmacéuticas, fabricación de PCB y procesamiento de alambres, ampliando la presencia de mercado de LPC.
레이저 포토닉스 (NASDAQ: LASE)는 자회사인 컨트롤 마이크로 시스템즈 (CMS)가 제약 및 전자 제조 고객으로부터 첨단 레이저 시스템에 대한 후속 주문을 다수 확보했다고 발표했습니다. 주문에는 한 대형 제약회사로부터의 UV 레이저 드릴링 시스템과 회로 기판 제조를 위한 PCB 레이저 마킹 워크스테이션이 포함됩니다.
UV 레이저 드릴링 시스템은 수냉식과 정밀한 홀 드릴링을 위한 통합 광학 비전 시스템을 특징으로 합니다. PCB 레이저 마킹 워크스테이션은 공랭식 CO2 레이저로 작동하며 맞춤형 컨베이어 구성 및 정밀 정렬을 위한 정교한 비전 시스템을 제공합니다. 두 시스템 모두 CDRH 클래스 I 준수 인클로저를 포함하고 있으며 CMS의 독점 소프트웨어를 사용하여 프로그래밍됩니다.
2024년 4분기 LPC에 인수된 이후, CMS는 제약, PCB 제조 및 와이어 가공 응용 분야를 위한 전문 레이저 장비에서 빠른 성장을 보여 LPC의 시장 존재감을 확장하고 있습니다.
Laser Photonics (NASDAQ: LASE) a annoncé que sa filiale Control Micro Systems (CMS) a obtenu plusieurs commandes de suivi pour des systèmes laser avancés de clients dans les secteurs pharmaceutique et de la fabrication d'électronique. Les commandes comprennent un Système de Perçage Laser UV d'une entreprise pharmaceutique de premier plan et une Station de Marquage Laser pour PCB pour la fabrication de circuits imprimés.
Le Système de Perçage Laser UV est doté d'un refroidissement à eau et d'un système de vision intégré à travers les optiques pour un perçage précis. La Station de Marquage Laser pour PCB, alimentée par un laser CO2 refroidi par air, offre des configurations de convoyeur personnalisées et des systèmes de vision sophistiqués pour un alignement à tolérance étroite. Les deux systèmes sont équipés de boîtiers conformes à la classe I du CDRH et sont programmés à l'aide du logiciel propriétaire de CMS.
Depuis son acquisition par LPC au quatrième trimestre 2024, CMS a montré une croissance rapide dans les équipements laser spécialisés pour les applications pharmaceutiques, la fabrication de PCB et le traitement de câbles, élargissant ainsi la présence sur le marché de LPC.
Laser Photonics (NASDAQ: LASE) hat bekannt gegeben, dass ihre Tochtergesellschaft Control Micro Systems (CMS) mehrere Folgeaufträge für fortschrittliche Lasersysteme von Kunden in der Pharma- und Elektronikfertigung gesichert hat. Die Aufträge umfassen ein UV-Laserbohrsystem von einem führenden Pharmaunternehmen und eine PCB-Laserbeschriftungsarbeitsstation für die Leiterplattenfertigung.
Das UV-Laserbohrsystem verfügt über eine Wasserkühlung und ein integriertes optisches Sichtsystem für präzise Bohrungen. Die PCB-Laserbeschriftungsarbeitsstation, betrieben mit einem luftgekühlten CO2-Laser, bietet maßgeschneiderte Förderkonfigurationen und anspruchsvolle Sichtsysteme für eine enge Toleranzanpassung. Beide Systeme sind mit CDRH Klasse I-konformen Gehäusen ausgestattet und werden mit der proprietären Software von CMS programmiert.
Seit der Übernahme durch LPC im vierten Quartal 2024 zeigt CMS ein rasantes Wachstum im Bereich spezialisierter Laserausrüstung für pharmazeutische Anwendungen, PCB-Fertigung und Drahtbearbeitung und erweitert damit die Marktpräsenz von LPC.
- Secured multiple repeat orders from established clients, indicating strong customer satisfaction
- Successfully expanding into diverse industrial verticals post-acquisition
- Demonstrated rapid growth since Q4 2024 acquisition
- None.
Insights
The repeat orders secured by Control Micro Systems represent a strategic milestone for Laser Photonics , validating their recent acquisition strategy and market positioning. The UV Laser Drilling System and PCB Laser Marking Workstation orders demonstrate three critical success factors:
- Strong customer retention and satisfaction, evidenced by repeat orders from established clients
- Successful penetration into high-value markets (pharmaceutical and electronics manufacturing)
- Effective cross-selling potential within LPC's expanded portfolio
The pharmaceutical industry's continued investment in UV laser drilling systems is particularly significant, as it indicates growing adoption of precision manufacturing technologies in regulated industries. This market segment typically offers higher margins and more stable revenue streams due to regulatory requirements and quality standards.
In the electronics manufacturing sector, the PCB Laser Marking Workstation order reflects the increasing automation and quality control requirements in circuit board production. The system's integration capabilities and vision-based quality control features address critical industry needs for precision and efficiency.
From an investor perspective, these developments suggest positive momentum in CMS's order book post-acquisition, potentially accelerating LPC's revenue growth and market expansion. The proprietary software and specialized applications also create barriers to entry, potentially leading to improved pricing power and margins.
Leading pharmaceutical manufacturer and electronics manufacturer place repeat orders
John Armstrong, Executive Vice President of LPC, commented:
“These orders for additional CMS laser systems across multiple industries demonstrate both the high levels of customer satisfaction CMS is bringing to the market and the growing market demand for advanced laser equipment across various verticals. These two factors point towards continued success for this recently acquired business.”
The first order is for CMS’s UV Laser Drilling System, a cutting-edge solution designed for high-precision applications. This automated, water-cooled system leverages a state-of-the-art ultraviolet laser and an integrated through-the-optics vision system, enabling accurate positioning for precise hole drilling. The client, a leading pharmaceutical company, has consistently relied on CMS’s expertise, placing multiple orders over the years.
The second order is for the PCB Laser Marking Workstation, which is tailored for marking printed circuit boards. This system, powered by an air-cooled CO2 laser, supports various PCB sizes and circuit arrays, offering custom conveyor configurations for seamless integration into assembly lines. Its sophisticated vision system ensures tight-tolerance alignment and code verification, making it a critical tool for efficient, high-quality production.
Both systems are engineered with the highest standards of safety and durability, featuring CDRH Class I compliant enclosures, robust welded steel construction, safe observation panels and easy access to the processing area. The systems are programmed using CMS’s proprietary software, offering intuitive and efficient control.
Since its acquisition by LPC in the fourth quarter of 2024, CMS has experienced rapid growth, driven by its expertise in specialized laser equipment for pharmaceutical, PCB manufacturing, wire processing and other industrial applications. Control Micro Systems has significantly enhanced LPC’s market differentiation and expanded its footprint into new industries.
About Laser Photonics Corporation
Laser Photonics is a vertically integrated manufacturer and R&D Center of Excellence for industrial laser technologies and systems. Laser Photonics seeks to disrupt the
Cautionary Note Concerning Forward-Looking Statements
This press release contains “forward-looking statements” (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended), including statements regarding the Company’s plans, prospects, potential results and use of proceeds. These statements are based on current expectations as of the date of this press release and involve a number of risks and uncertainties, which may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. These risks include, without limitation, those described under the caption “Risk Factors” in the Registration Statement. Any reader of this press release is cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release except as required by applicable laws or regulations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250124598632/en/
Investor Relations and Media Contact:
Brian Siegel, IRC®, M.B.A.
Senior Managing Director
Hayden IR
(346) 396-8696
brian@haydenir.com
Source: Laser Photonics Corporation
FAQ
What new orders did Laser Photonics (LASE) subsidiary CMS receive in 2024?
What are the key features of CMS's UV Laser Drilling System?
How has CMS performed since being acquired by Laser Photonics (LASE)?
What industries does Laser Photonics (LASE) serve through its CMS subsidiary?